Modified PicALuc Luciferase Enhances Bioluminescence

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current luciferase-based diagnostic techniques face limitations due to the need for excitation light, which can be phototoxic and result in low signal-background ratios, making them unsuitable for trace detection, and there is a need for smaller, non-cross-reactive luciferases with high expression levels and bright emission for enhanced detection sensitivity.

Innovation Solution

Development of a brighter variant of the smallest luciferase, picALuc, through structural modeling, molecular dynamics simulations, and mutational analysis, specifically by altering salt bridge interactions, resulting in increased enzymatic activity and bioluminescence without affecting thermal stability.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Illumination intensity

If fluorescent proteins, fluorescent dyes, or quantum dot are used as reporter proteins, then high fluorescence intensity is achieved, but phototoxicity to cells occurs and signal-background ratio becomes low

Engineering Contradiction:
Improvefluorescence intensityVSAvoidphototoxicity
Core Design Contradiction:
Illumination intensityVSObject-affected harmful factors

Solution Approach 1:

The patent replaces the fluorescent reporter system (which requires excitation light and produces fluorescence) with a bioluminescent luciferase system that generates light through a chemical reaction. This substitution eliminates the need for excitation light, thereby removing phototoxicity while maintaining high signal intensity through chemiluminescence rather than fluorescence.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent converts the harmful effect of requiring excitation light (which causes phototoxicity) into a benefit by using a self-luminous luciferase system. The luciferase enzyme catalyzes a chemical reaction that directly produces light without external excitation, transforming the limitation of fluorescent systems into an advantage of bioluminescent systems.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

2Illumination intensity

If fluorescent proteins, fluorescent dyes, or quantum dot are used as reporter proteins, then high fluorescence intensity is achieved, but excitation light spectrum overlaps with fluorescence spectrum resulting in low signal-background ratio

Engineering Contradiction:
Improvefluorescence intensityVSAvoidsignal-background ratio
Core Design Contradiction:
Illumination intensityVSMeasurement precision

Solution Approach 1:

The patent substitutes the fluorescent emission mechanism with a bioluminescent emission mechanism. Since luciferase generates light through a chemical reaction rather than absorbing and re-emitting excitation light, there is no spectral overlap between excitation and emission. This allows for excellent signal-background separation and high measurement precision in trace detection applications.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Measurement precision

If conventional luciferase enzymes are used, then detection is suitable for trace detection, but enzyme size is large and cross-reactivity with targets occurs

Engineering Contradiction:
Improvedetection sensitivityVSAvoidenzyme size
Core Design Contradiction:
Measurement precisionVSWeight of moving object

Solution Approach 1:

The patent applies segmentation by deleting specific functional regions from the conventional luciferase enzyme structure. The N-terminal region (residues 1-54) and C-terminal region (residues 175-194) are removed, retaining only the essential catalytic core. This segmentation reduces the enzyme size to 13 kDa while preserving luciferase activity and minimizing cross-reactivity with target proteins.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent extracts and removes unnecessary regions from the full-length luciferase enzyme. By taking out the N-terminal and C-terminal regions that are not essential for catalytic function, the patent creates a minimized luciferase variant that maintains detection sensitivity while reducing size and potential cross-reactivity issues.

Inventive Principle:
Principle #2Taking out (Extraction)

4Weight of moving object

If picALuc is used as the smallest luciferase, then enzyme size is reduced to 13 kDa, but enzymatic activity is insufficient for enhanced detection

Engineering Contradiction:
Improveenzyme sizeVSAvoidenzymatic activity
Core Design Contradiction:
Weight of moving objectVSProductivity

Solution Approach 1:

The patent applies parameter changes by systematically mutating specific amino acid residues in the picALuc enzyme structure. Through rational design and mutagenesis, the patent optimizes the catalytic parameters of the minimized luciferase to enhance its enzymatic activity. This allows the small 13 kDa enzyme to achieve sufficient productivity for sensitive detection applications.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The modified picALuc variant exhibits enhanced bioluminescence activity, with a significant increase in photon emission for the same enzyme and substrate amount, demonstrating improved detection sensitivity and utility in biological and biomedical assays.

Implementation Method 1

Luciferase does not require excitation light, and therefore it has none of the above-described drawbacks. Moreover, detection with luciferase is more suitable for trace detection than colorimetric methods which employ peroxidase and the like.

Methodology Applied
Scientific EffectBioluminescence: Bioluminescence

Data Source

PatentUS20240318151A1Modified Luciferases
Publication Date: 2024.09.26 QATAR FOUND FOR EDUCATION SCI & COMMUNITY DEV
  • US20240318151A1 patent drawing
  • US20240318151A1 patent drawing
  • US20240318151A1 patent drawing

AI summary

The instant disclosure relates to methods for luciferase modification.